Nano X Imaging Stock Today
| NNOX Stock | USD 5.74 0.09 1.54% |
PerformanceVery Weak
| Odds Of DistressLow
|
Nano X is trading at 5.74 as of the 19th of March 2025; that is 1.54 percent decrease since the beginning of the trading day. The stock's open price was 5.83. Nano X has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 21st of August 2020 | Category Healthcare | Classification Health Care |
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company was founded in 2011 and is headquartered in Neve Ilan, Israel. Nano-X Imaging is traded on NASDAQ Exchange in the United States. The company has 58.52 M outstanding shares of which 7.89 M shares are now shorted by private and institutional investors with about 2.95 trading days to cover. More on Nano X Imaging
Moving against Nano Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Nano Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Inc | Elli Yuz | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsNano X can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Nano X's financial leverage. It provides some insight into what part of Nano X's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nano X Imaging (NNOX) is traded on NASDAQ Exchange in USA. It is located in 94 Shlomo Shmeltzer Road, Petah Tikva, Israel, 4970602 and employs 164 people. Nano X is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 341.18 M. Nano X Imaging conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 58.52 M outstanding shares of which 7.89 M shares are now shorted by private and institutional investors with about 2.95 trading days to cover.
Nano X Imaging currently holds about 86.63 M in cash with (44.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.66.
Check Nano X Probability Of Bankruptcy
Ownership AllocationNano X Imaging maintains a total of 58.52 Million outstanding shares. Nano X Imaging secures 8.99 % of its outstanding shares held by insiders and 24.0 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Nano Ownership Details
Nano Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Hovey Youngman Associates Inc | 2024-12-31 | 192.4 K | |
| Susquehanna International Group, Llp | 2024-12-31 | 190.6 K | |
| Johnson & Johnson | 2024-12-31 | 158.9 K | |
| Bank Of New York Mellon Corp | 2024-12-31 | 146.6 K | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 132.3 K | |
| Nuveen Asset Management, Llc | 2024-12-31 | 131.5 K | |
| Squarepoint Ops Llc | 2024-12-31 | 122.3 K | |
| Tempus Wealth Planning, Llc | 2024-12-31 | 116.4 K | |
| Bnp Paribas Arbitrage, Sa | 2024-12-31 | 106.3 K | |
| Blackrock Inc | 2024-12-31 | 3.4 M | |
| Ubs Group Ag | 2024-12-31 | 1.4 M |
Nano X Historical Income Statement
Nano Stock Against Markets
Nano X Corporate Management
| Gali Attias | Chief Resources | Profile | |
| Marina Feler | Chief Officer | Profile | |
| Tal Shank | VP Devel | Profile | |
| MBA MD | USARAD CMO | Profile | |
| Ran Poliakine | Founder Chairman | Profile | |
| Tamar Cohen | Executive Officer | Profile | |
| Ran Daniel | Chief Officer | Profile |
Additional Tools for Nano Stock Analysis
When running Nano X's price analysis, check to measure Nano X's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nano X is operating at the current time. Most of Nano X's value examination focuses on studying past and present price action to predict the probability of Nano X's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nano X's price. Additionally, you may evaluate how the addition of Nano X to your portfolios can decrease your overall portfolio volatility.